Personalis, Inc. Share-based Payment Arrangement, Expense
Personalis, Inc. (PSNL) reported Share-based Payment Arrangement, Expense of $3.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-04
- Personalis, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $3.98M, a 40.67% increase year-over-year.
- Personalis, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $2.55M, a 15.05% increase year-over-year.
- Personalis, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $2.30M, a 13.90% decline year-over-year.
- Personalis, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $2.08M, a 22.23% decline year-over-year.
- Personalis, Inc. share-based payment arrangement, expense for fiscal 2025 was $9.43M, a 11.76% decline from fiscal 2024.
- Personalis, Inc. share-based payment arrangement, expense for fiscal 2024 was $10.69M, a 23.95% decline from fiscal 2023.
- Personalis, Inc. share-based payment arrangement, expense for fiscal 2023 was $14.05M, a 27.70% decline from fiscal 2022.
- Personalis, Inc. share-based payment arrangement, expense for fiscal 2022 was $19.43M, a 35.16% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.98M 10-Q · filed 2026-08-04 | $6.53M 10-Q · filed 2026-08-04 | $8.83M derived: sum of 3 quarters · filed 2026-08-04 | $10.91M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $2.55M 10-Q · filed 2026-05-07 | $4.85M derived: sum of 2 quarters · filed 2026-05-07 | $6.93M derived: sum of 3 quarters · filed 2026-05-07 | $9.76M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.38M derived: sum of 2 quarters · filed 2026-02-26 | $7.21M derived: sum of 3 quarters · filed 2026-08-04 | $9.43M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.08M 10-Q · filed 2025-11-04 | $4.91M derived: sum of 2 quarters · filed 2026-08-04 | $7.13M 10-Q · filed 2025-11-04 | $9.80M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $2.83M 10-Q · filed 2026-08-04 | $5.05M 10-Q · filed 2026-08-04 | $7.72M derived: sum of 3 quarters · filed 2026-08-04 | $10.39M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.22M 10-Q · filed 2026-05-07 | $4.89M derived: sum of 2 quarters · filed 2026-05-07 | $7.57M derived: sum of 3 quarters · filed 2026-05-07 | $10.22M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.35M derived: sum of 2 quarters · filed 2026-02-26 | $8.00M derived: sum of 3 quarters · filed 2026-02-26 | $10.69M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.68M 10-Q · filed 2025-11-04 | $5.33M derived: sum of 2 quarters · filed 2025-11-04 | $8.02M 10-Q · filed 2025-11-04 | $11.41M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $2.65M 10-Q · filed 2025-08-05 | $5.34M 10-Q · filed 2025-08-05 | $8.73M derived: sum of 3 quarters · filed 2025-08-05 | $12.21M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $2.69M 10-Q · filed 2025-05-06 | $6.08M derived: sum of 2 quarters · filed 2025-05-06 | $9.56M derived: sum of 3 quarters · filed 2025-05-06 | $13.04M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $6.87M derived: sum of 2 quarters · filed 2025-02-27 | $10.36M derived: sum of 3 quarters · filed 2025-02-27 | $14.05M 10-K · filed 2025-02-27 |
| 2023-09-30 | $3.48M 10-Q · filed 2024-11-06 | $6.97M derived: sum of 2 quarters · filed 2024-11-06 | $10.66M 10-Q · filed 2024-11-06 | $16.45M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $3.48M 10-Q · filed 2024-08-07 | $7.18M 10-Q · filed 2024-08-07 | $12.97M derived: sum of 3 quarters · filed 2024-08-07 | $17.38M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $3.69M 10-Q · filed 2024-05-08 | $9.48M derived: sum of 2 quarters · filed 2024-05-08 | $13.90M derived: sum of 3 quarters · filed 2024-05-08 | $18.31M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $10.20M derived: sum of 2 quarters · filed 2024-02-28 | $14.62M derived: sum of 3 quarters · filed 2024-02-28 | $19.43M 10-K · filed 2024-02-28 |
| 2022-09-30 | $4.42M 10-Q · filed 2023-11-07 | $8.83M derived: sum of 2 quarters · filed 2023-11-07 | $13.65M 10-Q · filed 2023-11-07 | $17.68M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $4.42M 10-Q · filed 2023-08-08 | $9.23M 10-Q · filed 2023-08-08 | $13.26M derived: sum of 3 quarters · filed 2024-02-28 | $16.95M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $4.82M 10-Q · filed 2023-05-03 | $8.85M derived: sum of 2 quarters · filed 2024-02-28 | $12.54M derived: sum of 3 quarters · filed 2024-02-28 | $16.14M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $7.72M derived: sum of 2 quarters · filed 2024-02-28 | $11.32M derived: sum of 3 quarters · filed 2024-02-28 | $14.38M 10-K · filed 2024-02-28 |
| 2021-09-30 | $3.69M 10-Q · filed 2022-11-02 | $7.29M derived: sum of 2 quarters · filed 2022-11-02 | $10.35M 10-Q · filed 2022-11-02 | $13.82M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $3.60M 10-Q · filed 2022-08-03 | $6.66M 10-Q · filed 2022-08-03 | $10.13M derived: sum of 3 quarters · filed 2023-02-23 | $11.82M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $3.06M 10-Q · filed 2022-05-04 | $6.53M derived: sum of 2 quarters · filed 2023-02-23 | $8.22M derived: sum of 3 quarters · filed 2023-02-23 | $10.05M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $5.17M derived: sum of 2 quarters · filed 2023-02-23 | $6.99M derived: sum of 3 quarters · filed 2023-02-23 | $8.24M 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.69M 10-Q · filed 2021-11-04 | $3.51M derived: sum of 2 quarters · filed 2021-11-04 | $4.76M 10-Q · filed 2021-11-04 | $5.96M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $1.82M 10-Q · filed 2021-08-04 | $3.07M 10-Q · filed 2021-08-04 | $4.27M derived: sum of 3 quarters · filed 2022-02-24 | $5.67M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $1.25M 10-Q · filed 2021-05-05 | $2.45M derived: sum of 2 quarters · filed 2022-02-24 | $3.85M derived: sum of 3 quarters · filed 2022-02-24 | $5.50M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.60M derived: sum of 2 quarters · filed 2022-02-24 | $4.25M derived: sum of 3 quarters · filed 2022-02-24 | $4.86M 10-K · filed 2022-02-24 |
| 2019-09-30 | $1.40M 10-Q · filed 2020-11-05 | $3.05M derived: sum of 2 quarters · filed 2020-11-05 | $3.66M 10-Q · filed 2020-11-05 | $4.05M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.65M 10-Q · filed 2020-08-06 | $2.25M 10-Q · filed 2020-08-06 | $2.65M derived: sum of 3 quarters · filed 2021-02-25 | $2.99M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $609.00K 10-Q · filed 2020-05-07 | $1.00M derived: sum of 2 quarters · filed 2021-02-25 | $1.34M derived: sum of 3 quarters · filed 2021-02-25 | $1.76M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $734.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.15M derived: sum of 3 quarters · filed 2021-02-25 | $1.32M 10-K · filed 2021-02-25 |
| 2018-09-30 | $341.00K 10-Q · filed 2019-11-13 | $755.00K derived: sum of 2 quarters · filed 2019-11-13 | $924.00K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $414.00K 10-Q · filed 2019-08-13 | $583.00K 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | $753.00K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |